MetLife stock trades at USD 97.25 as Q3 estimate emerges
AD HOC NEWS
MetLife's stock traded at USD 97.25 on September 24, 2026, after the insurer provided a preliminary Q3 variable investment income estimate of at least USD 600 million pre-tax. This estimate offers an early indication of Q3 performance ahead of the scheduled results on November 4, 2026. The company also reported strong Q2 2026 earnings, with adjusted EPS up 20% year-over-year, and received an "Overweight" rating from Piper Sandler with a USD 110.00 price target.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.